Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development.
Recent progress in omics-driven analysis of MS to unravel pathological mechanisms.
Inflammatory demyelination induces glia alterations and ganglion cell loss in the retina of anexperimental autoimmune encephalomyelitis model.
[Autonomic neuropathies].
Comparison of deep gray matter lesions on magnetic resonance imaging among adults with acute disseminated encephalomyelitis, multiple sclerosis, and neuromyelitis optica.
Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis.
Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.
Intention tremor and deficits of sensory feedback control in multiple sclerosis: a pilot study.
Treatment responsiveness in CIDP patients with diabetes is associated with unique electrophysiological characteristics, and not with common criteria for CIDP.
MCAM(+) CD8 T lymphocytes mediate CNS inflammation.
Cytomegalovirus associated transverse myelitis in an immunocompetent host with DNA detection in cerebrospinal fluid; a case report.
Immunomodulation by Transplanted Human Embryonic Stem Cell- Derived Oligodendroglial Progenitors in Experimental Autoimmune Encephalomyelitis.
Magnetic resonance imaging in neuromyelitis optica.
Disease-specific therapy of idiopathic inflammatory demyelinating disorders.
A case of neuromyelitis optica associated with anti-aquaporin 4 antibody and other autoantibodies.
[Neuro-ophthalmology: the eye as a window to the brain].
NMR and pattern recognition methods in metabolomics: From data acquisition to biomarker discovery: A review.
Cognitive Trajectories in 4 Patients With Pediatric-Onset Multiple Sclerosis: Serial Evaluation Over a Decade.
[Therapy adherence to immunomodulator treatment in patients with multiple sclerosis].
Neurobehavioral disorders.
Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses.
Neuropsychological rehabilitation does not improve cognitive performance but reduces perceived cognitive deficits in patients with multiple sclerosis: a randomised, controlled, multi-centre trial.
Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes.
MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
Human Endogenous Retrovirus HERV-Fc1 Association with Multiple Sclerosis Susceptibility: A Meta-Analysis.
Pages
« first
‹ previous
…
356
357
358
359
360
361
362
363
364
…
next ›
last »